Home > Insider Trading > Filing (0000950142-14-000705)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1544116	Durata Therapeutics Inc.	DRTX	Pharmaceutical Preparations (2834)	871247903

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	888 Seventh Avenue 30Th Fl New York NY 10106	No	No	Yes	No
1250195	Steve Elms	888 Seventh Avenue 30Th Fl New York NY 10106	No	No	Yes	No
1297291	J Dennis Purcell	888 Seventh Avenue 30Th Fl New York NY 10106	No	No	Yes	No
1444717	Aisling Capital Iii Lp	888 Seventh Avenue 30Th Fl New York NY 10106	No	No	Yes	No
1532634	Aisling Capital Partners Iii Lp	888 Seventh Avenue 30Th Fl New York NY 10106	No	No	Yes	No
1532635	Aisling Capital Partners Iii Llc	888 Seventh Avenue 30Th Fl New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-20	98,000	$15.74	3,032,824	No	4	S	Indirect	By Aisling Capital III, LP
Common Stock	Disposition	2014-03-21	2,649	$15.57	3,030,175	No	4	S	Indirect	By Aisling Capital III, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Aisling Capital III, LP
No	4	S	Indirect	By Aisling Capital III, LP

Footnotes

These shares of common stock are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP") , as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling. (Continued in FN 2)
(Continued from FN 1) Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons may be deemed to be the beneficial owner of the securities reported herein only to the extent of its pecuniary interest therein. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that any of the Reporting Persons is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities reported herein in excess of such amount.